Skip to main content
Premium Trial:

Request an Annual Quote

Colin Collins, Derek Potter

Premium
CombiMatrix has appointed Colin Collins to the scientific advisory board of its subsidiary, CombiMatrix Molecular Diagnostics. Collins is associate professor of urology at the Cancer Research Institute and the department of molecular medicine at the University of California, San Francisco.
 
Collins’ research has led to the identification of genetic markers that have been used to risk-stratify cancer patients. He also invented a method of analyzing the structure of tumor genomes called end sequence profiling.
 

 
BioTrove has appointed Derek Potter to be director of European business operations, a position based in London. Potter formerly was European sales manager for Applied Biosystems, and he was involved in establishing Fluidigm’s European operations.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.